FDA FOIA Monitor
FDA GLP-1 FOIA Monitor | Ozempic, Wegovy, Zepbo...
Interest in GLP-1 medications has grown rapidly, making them one of the most requested topics under the Freedom of Information Act (FOIA). This page tracks FDA FOIA requests involving semaglutide,...
FDA GLP-1 FOIA Monitor | Ozempic, Wegovy, Zepbo...
Interest in GLP-1 medications has grown rapidly, making them one of the most requested topics under the Freedom of Information Act (FOIA). This page tracks FDA FOIA requests involving semaglutide,...
FDA FOIA Monitor 1.2 Released July 2026
FDA's FOIA office rebounded in June after a slow spring: median processing time dropped 38% in a single month, and the release rate climbed back to 74%. Also this issue:...
FDA FOIA Monitor 1.2 Released July 2026
FDA's FOIA office rebounded in June after a slow spring: median processing time dropped 38% in a single month, and the release rate climbed back to 74%. Also this issue:...
Introducing the FDA FOIA Monitor
FDA FOIA Monitor: Special Edition, 2015–2026 Baseline Report foiadocs.com · Special Edition FDA FOIA Monitor 2015–2026 Baseline Report Special Edition Data Through June 2026 Source: FDA FOIA Log · 2015–2026...
Introducing the FDA FOIA Monitor
FDA FOIA Monitor: Special Edition, 2015–2026 Baseline Report foiadocs.com · Special Edition FDA FOIA Monitor 2015–2026 Baseline Report Special Edition Data Through June 2026 Source: FDA FOIA Log · 2015–2026...